|
P2-151 O-T03C-0361
Biomaterials for theranostics
-
Drug delivery
Development of drug-loaded torus-shaped alginate microparticles for its sustained release
Kazuki Matsumiya
|
|
P2-152 P-T03C-1513
Biomaterials for theranostics
-
Drug delivery
Design of a photocleavable amphiphilic conjugate for light-driven engineered platelets
Tsuyoshi Doko
|
|
P2-153 O-T03C-0098
Biomaterials for theranostics
-
Drug delivery
Intratumoral pH-activated nanocytokines induce tumor-specific immune activation to enhance anticancer immunotherapy
Pengwen Chen
|
|
P2-154 E-T03C-1271
Biomaterials for theranostics
-
Drug delivery
Polyoxazolines conjugated with galectin-3 inhibitors – a novel drug delivery system for the treatment of pulmonary hypertension
Antonín Sedlář
|
|
P2-155 O-T03C-1098
Biomaterials for theranostics
-
Drug delivery
Breaking-down tumoral physical barrier by “on-site” unwrapping metal-polyphenol-packaged hyaluronidase for optimizing photothermal/photodynamic therapy-induced immune response
Quanwei Sun
|
|
P2-156 E-T03C-2361
Biomaterials for theranostics
-
Drug delivery
Polyplex Nanomicelles and Lipid Nanoparticles: Comprehensive analyses for mRNA Delivery
Xuan Du
|
|
P2-157 E-T03C-0738
Biomaterials for theranostics
-
Drug delivery
Synthetic molecular motor activates drug delivery from polymersomes
Ainoa Guinart Planellas
|
|
P2-158 O-T03F-0368
Biomaterials for theranostics
-
Immunomodulatory biomaterials
Immune cell death on catheter surfaces leads to greater biofilm formation on the surface upon infection
Sameer Kumar Jagirdar
|
|
P2-159 P-T03C-1512
Biomaterials for theranostics
-
Drug delivery
Preparation of biodegradable polyion complex sheets for trans pericardial drug delivery
Yamato Fujita
|
|
P2-160 O-T03C-1689
Biomaterials for theranostics
-
Drug delivery
Phosphorous dendrimers co-deliver protein and drug to tackle osteoarthritis via mitochondrial function restoration and synergistic oxygen generation-mediated macrophage reprogrammin
Huxiao Sun
|
|
P2-161 O-T03C-0935
Biomaterials for theranostics
-
Drug delivery
Delivery of CRISPR/Cas9 plasmid DNA using lysine-based cationic lipid nanoparticle
Wenhan Sung
|
|
P2-162 O-T03C-0712
Biomaterials for theranostics
-
Drug delivery
Assessing the ability of dual loaded core-shell microgels to reduce markers of cardiac fibrosis on linear and non-linear elastic cardiac-mimetics
Aryssa Simpson
|
|
P2-163 O-T03C-0036
Biomaterials for theranostics
-
Drug delivery
Effective management of oral cancer pain through GPCR-targeted nanomedicine
Divya Bhansali
|
|
P2-164 E-T03C-0764
Biomaterials for theranostics
-
Drug delivery
Liposomes decorated with antifungal peptide penetratin exhibit enhanced antifungal activity against Candida spp.
Veronica LaMastro
|
|
P2-165 E-T03C-1045
Biomaterials for theranostics
-
Drug delivery
Lignin-based nanoparticles with phthalocyanine functionality for photothermal treatment of bacterial biofilm
Giulia Crivello
|
|
P2-166 P-T03C-1614
Biomaterials for theranostics
-
Drug delivery
Preparation of disulfide bond-crosslinked microparticles derived from a trehalose derivative having two mercapto groups and enzymatically synthesized oligocysteine
Tomohito Tatekawa
|
|
P2-167 E-T03C-0905
Biomaterials for theranostics
-
Drug delivery
Optimizing ionizable lipid tails for liver and non-liver delivery of mRNA lipid nanoparticles
Kaitlin Mrksich
|
|
P2-168 E-T03C-0956
Biomaterials for theranostics
-
Drug delivery
Sustained release crystalline anti-tuberculosis drug formulations for patient compliant tuberculosis treatment.
Nisha Barge
|
|
P2-169 E-T03C-0954
Biomaterials for theranostics
-
Drug delivery
Growth factor delivery through in-situ crosslinking hydrogel for the treatment of osteoarthritis
Bhagyashree Padhan
|
|
P2-170 P-T03C-1522
Biomaterials for theranostics
-
Drug delivery
Evaluation of the uptake behavior of anti-inflammatory agents conjugated poly(L-lysine) into platelets.
Rina Yokoi
|
|
P2-171 E-T03C-2763
Biomaterials for theranostics
-
Drug delivery
Feasibility of cationized gelatin nanospheres in mitochondria transplantation for enhancement of cell functions
WENXUAN YANG
|
|
P2-172 O-T03C-0948
Biomaterials for theranostics
-
Drug delivery
Development of Bryostatin-1 incorporated liposome-based nasal drug delivery system for hay fever treatment
Jiayue Li
|
|
P2-173 O-T03C-0074
Biomaterials for theranostics
-
Drug delivery
Combination of platinum-doped CaCO3 and Amylopectin-based gel to synergize with radiotherapy for High-grade Glioma
Jason Lin
|
|
P2-174 O-T03C-0499
Biomaterials for theranostics
-
Drug delivery
Chemically triggered conformational change of polymeric nano-assemblies for in situ generation of multivalent ligands of cancer cells
Rentaro Sakamoto
|
|
P2-175 E-T03C-1840
Biomaterials for theranostics
-
Drug delivery
Enhancing the efficacy of anti-scar drug through advanced solid lipid nanoparticle formulation, optimization, and targeted delivery strategies
Farinaz Jonidi Shariatzadeh
|
|
P2-176 E-T03C-1034
Biomaterials for theranostics
-
Drug delivery
The Enzyme-Responsive Delivery System for Reprogramming Reactive Glia into Neural Progenitors and Neurons
Zahra Eivazi Zadeh
|
|
P2-177 P-T03C-2154
Biomaterials for theranostics
-
Drug delivery
Chitosan-based nanocapsules with hyaluronan synthase for increasing endogenous hyaluronic acid production
Yong-Ji Chen
|
|
P2-178 O-T03C-0258
Biomaterials for theranostics
-
Drug delivery
Macrophage-Targeted Delivery of Immunomodulatory Drugs to Promote Tissue Repair
Shreya Soni
|
|
P2-179 E-T03C-2757
Biomaterials for theranostics
-
Drug delivery
The mechanistic study on platelet pyroptosis delivery system with miR-223 in diabetic vascular complication
Yiqiu Cao
|
|
P2-180 E-T03C-0869
Biomaterials for theranostics
-
Drug delivery
Microbur: a biomimetic platform for oral delivery of therapeutic
Suwan Ding
|
Login
